FreeTrader
17-01-07, 05:13 PM
من بريفنق
HMA +6.6% (announces $10/sh special dividend as part of a recapitalization, however, co will suspend regular dividend, will record $200 mln of additional bad debt expense), WIT +5.9% (reports DecQ, beats handily on revs), ASML +6.4% (reports Q4), TRNS +4.9% (reports Q3), LOGI +4.8% (bounces after 6% drop yesterday, co reports tomorrow in pre-mkt), HIHO +4.8% (extends yesterday's 22% move), STSI +14% (expects court rulings on Friday), GIII +4.7% (extends recent momentum, +13% in 4 days), TSS +5.5% (reports Q4), PH +4.9% (reports DecQ, beats by $0.15), GERN +4.1% (announces new benefit of its stem cell therapy), TELK +3.9% (Carl Icahn reports large stake), CHKP +1.4% (Credit Suisse upgrade), GSK +1.2%, MCD +1% (guides higher), AAPL +0.5% (TheRegister.com reports that Apple may have better legal chance at using the iPhone trademark).... Under $3: XOMA +6% (adds new programs to collaboration with SGP), GNVC +4% (to test malaria vaccine).
HMA +6.6% (announces $10/sh special dividend as part of a recapitalization, however, co will suspend regular dividend, will record $200 mln of additional bad debt expense), WIT +5.9% (reports DecQ, beats handily on revs), ASML +6.4% (reports Q4), TRNS +4.9% (reports Q3), LOGI +4.8% (bounces after 6% drop yesterday, co reports tomorrow in pre-mkt), HIHO +4.8% (extends yesterday's 22% move), STSI +14% (expects court rulings on Friday), GIII +4.7% (extends recent momentum, +13% in 4 days), TSS +5.5% (reports Q4), PH +4.9% (reports DecQ, beats by $0.15), GERN +4.1% (announces new benefit of its stem cell therapy), TELK +3.9% (Carl Icahn reports large stake), CHKP +1.4% (Credit Suisse upgrade), GSK +1.2%, MCD +1% (guides higher), AAPL +0.5% (TheRegister.com reports that Apple may have better legal chance at using the iPhone trademark).... Under $3: XOMA +6% (adds new programs to collaboration with SGP), GNVC +4% (to test malaria vaccine).